These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35073319)

  • 1. AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model.
    Lin K; Good SS; Julander JG; Weight AE; Moussa A; Sommadossi JP
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009937. PubMed ID: 35073319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
    Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
    Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of T-1106 in a hamster model of yellow Fever virus infection.
    Julander JG; Furuta Y; Shafer K; Sidwell RW
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
    Zandi K; Amblard F; Amichai S; Bassit L; Tao S; Jiang Y; Zhou L; Ollinger Russell O; Mengshetti S; Schinazi RF
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.
    Julander JG; Bantia S; Taubenheim BR; Minning DM; Kotian P; Morrey JD; Smee DF; Sheridan WP; Babu YS
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6607-14. PubMed ID: 25155605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.
    Julander JG; Shafer K; Smee DF; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2009 Jan; 53(1):202-9. PubMed ID: 18955536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.
    Julander JG; Morrey JD; Blatt LM; Shafer K; Sidwell RW
    Antiviral Res; 2007 Feb; 73(2):140-6. PubMed ID: 17049380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
    Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
    Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
    Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
    Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
    de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir efficacy against yellow fever in a hamster model.
    Julander JG; Bunyan E; Jordan R; Porter DP
    Antiviral Res; 2022 Jul; 203():105331. PubMed ID: 35533777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus).
    Rodrigues SG; da Rosa AP; Galler R; Barros VL; Vieira Cde M; da Rosa JF; Azevedo Rdo S; Nunes MR; da Rosa ES; Vasconcelos PF
    Rev Soc Bras Med Trop; 2004; 37 Suppl 2():69-74. PubMed ID: 15586900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
    Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
    Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model.
    Julander JG; Ennis J; Turner J; Morrey JD
    Antimicrob Agents Chemother; 2011 May; 55(5):2067-73. PubMed ID: 21300837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
    Chen YL; Yin Z; Lakshminarayana SB; Qing M; Schul W; Duraiswamy J; Kondreddi RR; Goh A; Xu HY; Yip A; Liu B; Weaver M; Dartois V; Keller TH; Shi PY
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3255-61. PubMed ID: 20516277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characterization of Hamster-Adapted Yellow Fever Virus.
    McArthur MA; Zhang SL; Li L; Tesh RB; Barrett ADT
    Vector Borne Zoonotic Dis; 2020 Mar; 20(3):222-227. PubMed ID: 31794691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model.
    Julander JG; Thibodeaux BA; Morrey JD; Roehrig JT; Blair CD
    Antiviral Res; 2014 Mar; 103():32-8. PubMed ID: 24393669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).
    Ono L; Wollinger W; Rocco IM; Coimbra TL; Gorin PA; Sierakowski MR
    Antiviral Res; 2003 Nov; 60(3):201-8. PubMed ID: 14638396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.